Nicholas J. Bach

1.3k total citations
31 papers, 1.1k citations indexed

About

Nicholas J. Bach is a scholar working on Organic Chemistry, Molecular Biology and Oncology. According to data from OpenAlex, Nicholas J. Bach has authored 31 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Organic Chemistry, 10 papers in Molecular Biology and 7 papers in Oncology. Recurrent topics in Nicholas J. Bach's work include Carbohydrate Chemistry and Synthesis (7 papers), Protein Kinase Regulation and GTPase Signaling (7 papers) and Plant and fungal interactions (6 papers). Nicholas J. Bach is often cited by papers focused on Carbohydrate Chemistry and Synthesis (7 papers), Protein Kinase Regulation and GTPase Signaling (7 papers) and Plant and fungal interactions (6 papers). Nicholas J. Bach collaborates with scholars based in United States. Nicholas J. Bach's co-authors include Edmund C. Kornfeld, Homer L. Pearce, James A. Clemens, E. Barry Smalstig, William T. Beck, Mark A. Winter, Ahmad R. Safa, Margaret C. Cirtain, Robert D. Dillard and David W. Snyder and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Endocrinology and Journal of Medicinal Chemistry.

In The Last Decade

Nicholas J. Bach

30 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Nicholas J. Bach United States	13	576	285	253	129	121	31	1.1k
Francis Bitsch Switzerland	21	1.2k 2.1×	323 1.1×	341 1.3×	108 0.8×	285 2.4×	31	1.9k
Jon P. Miller United States	25	1.3k 2.2×	381 1.3×	130 0.5×	59 0.5×	112 0.9×	51	1.8k
Paul M. Epstein United States	26	1.5k 2.7×	226 0.8×	248 1.0×	320 2.5×	66 0.5×	64	2.0k
J. PLUSCEC United States	12	732 1.3×	186 0.7×	137 0.5×	90 0.7×	87 0.7×	19	1.1k
Carla M. Suto United States	16	926 1.6×	176 0.6×	163 0.6×	119 0.9×	283 2.3×	21	1.2k
Gary L. Olson United States	19	774 1.3×	469 1.6×	114 0.5×	116 0.9×	41 0.3×	37	1.2k
Robert D. Dillard United States	16	489 0.8×	406 1.4×	59 0.2×	97 0.8×	97 0.8×	39	980
P.M. Woollard United Kingdom	19	403 0.7×	276 1.0×	114 0.5×	179 1.4×	45 0.4×	25	1.2k
David Thomson United States	20	361 0.6×	265 0.9×	80 0.3×	233 1.8×	161 1.3×	59	1.1k
Katrina L. Creech United States	16	429 0.7×	279 1.0×	651 2.6×	85 0.7×	192 1.6×	23	1.4k

Countries citing papers authored by Nicholas J. Bach

Since Specialization

Citations

This map shows the geographic impact of Nicholas J. Bach's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicholas J. Bach with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicholas J. Bach more than expected).

Fields of papers citing papers by Nicholas J. Bach

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicholas J. Bach. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicholas J. Bach. The network helps show where Nicholas J. Bach may publish in the future.

Co-authorship network of co-authors of Nicholas J. Bach

This figure shows the co-authorship network connecting the top 25 collaborators of Nicholas J. Bach. A scholar is included among the top collaborators of Nicholas J. Bach based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicholas J. Bach. Nicholas J. Bach is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Snyder, David W., Nicholas J. Bach, Robert D. Dillard, et al.. (1999). Pharmacology of LY315920/S-5920, [[3-(Aminooxoacetyl)-2-ethyl-1-(phenylmethyl)-1 H-indol-4-yl]oxy]acetate, a Potent and Selective Secretory Phospholipase A2Inhibitor: A New Class of Anti-Inflammatory Drugs, SPI. Journal of Pharmacology and Experimental Therapeutics. 288(3). 1117–1124. 70 indexed citations

Draheim, Susan E., Nicholas J. Bach, Robert D. Dillard, et al.. (1997). ChemInform Abstract: Indole Inhibitors of Human Nonpancreatic Secretory Phospholipase A2. Part 3. Indole‐3‐glyoxamides.. ChemInform. 28(16). 3 indexed citations

Fox, Niles, Min Song, James Schrementi, et al.. (1996). Transgenic model for the discovery of novel human secretory non-pancreatic phospholipase A2 inhibitors. European Journal of Pharmacology. 308(2). 195–203. 32 indexed citations

Sawyer, J. Scott, K. Jeff Thrasher, Nicholas J. Bach, et al.. (1996). Quinoline-substituted dihydroindoles as cysLT1 (LTD4 receptor) antagonists. Bioorganic & Medicinal Chemistry Letters. 6(3). 249–252. 6 indexed citations

Draheim, Susan E., Nicholas J. Bach, Robert D. Dillard, et al.. (1996). Indole Inhibitors of Human Nonpancreatic Secretory Phospholipase A₂. 3. Indole-3-glyoxamides. Journal of Medicinal Chemistry. 39(26). 5159–5175. 76 indexed citations

Fleisch, J H, Edward D. Mihelich, Stephen M. Spaethe, et al.. (1996). Recombinant human secretory phospholipase A2 released thromboxane from guinea pig bronchoalveolar lavage cells: in vitro and ex vivo evaluation of a novel secretory phospholipase A2 inhibitor.. Journal of Pharmacology and Experimental Therapeutics. 278(1). 252–257. 19 indexed citations

Schevitz, Richard W., Nicholas J. Bach, Nickolay Y. Chirgadze, et al.. (1995). Structure-based design of the first potent and selective inhibitor of human non-pancreatic secretory phospholipase A2. Nature Structural & Molecular Biology. 2(6). 458–465. 188 indexed citations

Sawyer, J. Scott, Nicholas J. Bach, Stephen Baker, et al.. (1995). Synthetic and Structure/Activity Studies on Acid-Substituted 2-Arylphenols: Discovery of 2-[2-Propyl-3-[3-[2-ethyl-4-(4-fluorophenyl)-5-hydroxyphenoxy]- propoxy]phenoxy]benzoic Acid, a High-Affinity Leukotriene B4 Receptor Antagonist. Journal of Medicinal Chemistry. 38(22). 4411–4432. 36 indexed citations

Sawyer, J. Scott, Nicholas J. Bach, Stephen Baker, et al.. (1994). Structural analogues of LY292728, a highly potent xanthone dicarboxylic acid leukotriene B4 receptor antagonist: spatial positioning of the secondary acid group. Bioorganic & Medicinal Chemistry Letters. 4(17). 2077–2082. 4 indexed citations

10.

Sofia, Michael J., Paul E. Floreancig, Nicholas J. Bach, et al.. (1993). o-Phenylphenols: potent and orally active leukotriene B4 receptor antagonists. Journal of Medicinal Chemistry. 36(24). 3978–3981. 8 indexed citations

11.

Wheeler, William J., et al.. (1990). The synthesis of [²H], [³H], and [¹⁴C]‐labeled 8β‐[(methylthio)methyl]‐6‐propylergoline mesylate (pergolide mesylate), a potent, long‐acting dopamine agonist. Journal of Labelled Compounds and Radiopharmaceuticals. 28(3). 273–295. 7 indexed citations

12.

Pearce, Homer L., et al.. (1989). Synthesis of 2-azapodophyllotoxin. Tetrahedron Letters. 30(8). 907–910. 37 indexed citations

13.

Pearce, Homer L., et al.. (1988). Modulation of multiple drug resistance mdr in cem vlb 100 cells structure activity relationships in a series of 100 reserpine analogs. 29. 299. 1 indexed citations

14.

Bach, Nicholas J., et al.. (1980). Conversion of ergolines to hexahydro- and octahydrobenzo[f]quinolines (depyrroloergolines). Journal of Medicinal Chemistry. 23(7). 812–814. 10 indexed citations

15.

Bach, Nicholas J., Edmund C. Kornfeld, James A. Clemens, & E. Barry Smalstig. (1980). ChemInform Abstract: CONVERSION OF ERGOLINES TO HEXAHYDRO‐ AND OCTAHYDROBENZO(F)QUINOLINES (DEPYRROLOERGOLINES). Chemischer Informationsdienst. 11(49). 1 indexed citations

16.

Bach, Nicholas J., Edmund C. Kornfeld, James A. Clemens, E. Barry Smalstig, & Robert C.A. Frederickson. (1980). Preparation and biological evaluation of 2-azaergolines. Journal of Medicinal Chemistry. 23(5). 492–494. 7 indexed citations

17.

Fuller, Ray W., James A. Clemens, Edmund C. Kornfeld, et al.. (1979). Effects of (8β)-8-[(Methylthio)methyl]-6-propylergoline on dopaminergic function and brain dopamine turnover in rats. Life Sciences. 24(4). 375–382. 88 indexed citations

18.

Bach, Nicholas J., David A. Hall, & Edmund C. Kornfeld. (1974). Descarboxylysergic acid (9,10-didehydro-6-methylergoline). Journal of Medicinal Chemistry. 17(3). 312–314. 11 indexed citations

19.

Bach, Nicholas J., et al.. (1974). ChemInform Abstract: DESCARBOXYLYSERGIC ACID (9,10‐DIHYDRO‐6‐METHYLERGOLINE). Chemischer Informationsdienst. 5(33). 1 indexed citations

20.

Clemens, James A., et al.. (1974). Inhibition of Prolactin Secretion by Ergolines. Endocrinology. 94(4). 1171–1176. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact